Hydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effect
2008
Improving Cancer Treatment with Hydroxycamptothecin-Loaded Nanoparticles
Sample size: 6
publication
Evidence: moderate
Author Information
Author(s): Wang Anxun, Li Su
Primary Institution: Sun Yat-sen University, Guangzhou, China
Hypothesis
Can hydroxycamptothecin-loaded nanoparticles enhance drug delivery and anticancer effects?
Conclusion
HCPT-loaded nanoparticles provide a more sustained release and enhanced anticancer effect compared to free HCPT.
Supporting Evidence
- The drug-loading capacity of HCPT-loaded nanoparticles was 7.5%.
- The terminal elimination half-life of HCPT-loaded nanoparticles was longer than that of free HCPT.
- Tumor inhibition in the HCPT-loaded nanoparticle treated group was significantly higher than that of the HCPT treated group.
Takeaway
Scientists made tiny balls that carry a cancer drug to help it work better and last longer in the body.
Methodology
HCPT-loaded nanoparticles were prepared using a dialysis method and their characteristics were evaluated through various tests including UV spectrophotometry and HPLC.
Participant Demographics
New Zealand rabbits and BALB/c nude mice were used in the study.
Statistical Information
P-Value
p < 0.01
Statistical Significance
p < 0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website